Improved adherence to antiretroviral therapy observed among HIV-infected children whose caregivers had positive beliefs in medicine in Sub-Saharan Africa

Samankaltaisia teoksia

• Abacavir, zidovudine, or stavudine as paediatric tablets for African HIV-infected children (CHAPAS-3): an open-label, parallel-group, randomised controlled trial.
  Tekijä: Mulenga, V, et al.
  Julkaistu: (2016)
• Anthropometric measurements and lipid profiles to detect early lipodystrophy in antiretroviral therapy experienced HIV-infected children in the CHAPAS-3 trial.
  Tekijä: Musiime, V, et al.
  Julkaistu: (2014)
• Excellent adherence to antiretrovirals in HIV+ Zambian children is compromised by disrupted routine, HIV nondisclosure, and paradoxical income effects
  Tekijä: Haberer, J, et al.
  Julkaistu: (2011)
• Predicting patterns of long-term CD4 reconstitution in HIV-infected children starting antiretroviral therapy in sub-Saharan Africa: a cohort-based modelling study.
  Tekijä: Picat, M, et al.
  Julkaistu: (2013)
• Prevalence of lipodystrophy and metabolic abnormalities in HIV-infected African children after 3 years on first-line antiretroviral therapy.
  Tekijä: Bwakura-Dangarembizi, M, et al.
  Julkaistu: (2015)